Canada to pause 1st batch of J&J COVID vax over quality issues

TORONTO: Health Canada is set to pause the first batch of 300,000 Johnson & Johnson Covid-19 jabs after learning that a part of the vaccine was made in the same US plant where millions of doses were spoiled, the media reported. The Candian government agency found that a "drug substance" needed to become the final J&J vaccine was made at the Emergent Biosolutions plant in Baltimore, Maryland, the globalnews.ca reported. "The drug substance is the active ingredient that undergoes further processing before becoming the final product (i.e., the vaccine). The final Janssen vaccines were manufactured at a different site located outside of the US," the agency was quoted as saying in a statement. The plant has been in news for several violations, including cleaning and sterilisation as well as the potential for cross-contamination. The US Food and Drug Administration (FDA) has since ordered the facility to stop making more J&J vaccines until it addresses the violations and manufacturing errors, which resulted in 15 millions of those doses being destroyed, the report said. (IANS)

Also Read: Ontario to donate 3,000 ventilators to Indian Red Cross to fight pandemic

Also Watch: Assam Election Result, 2021: Counting of Votes Underway, Candidates Confident